openPR Logo
Press release

Neurovascular Devices Market Like to Touch $3,409 Million by 2023

02-27-2020 06:22 AM CET | Health & Medicine

Press release from: Allied Market Research

Neurovascular Devices Market

Neurovascular Devices Market

Neurovascular Devices Market was valued at $2,371 million in 2016, and is projected to reach $3,409 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The embolization devices segment held more than two-fifths share of the total market in 2016.

Neurovascular devices are used for the treatment of neurovascular disorders such as cerebral aneurysm. Increase in geriatric population and rise in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, surge in adoption of new minimally invasive devices such as flow diversion and carotid artery stents boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/2278

Embolization devices segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of neurovascular disorders, such as arteriovenous malformations (AVMs), carotid artery disease, and intracranial atherosclerotic disease. On the other hand, revascularization devices segment is expected to grow at the highest CAGR of 8.5% during the forecast period.

Key Findings of the Neurovascular Devices Market:
o Revascularization devices segment is projected to grow at a CAGR of 8.5% during the forecast period.
o Aneurysm contributed for nearly three-fifths share of the global neurovascular devices market in 2016.
o Ischemic stroke segment is expected to register the highest CAGR of 5.7% during the analysis period.
o France and Germany jointly contributed for more than one-third share of the European neurovascular devices market in 2016.
o Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific neurovascular devices market in 2016.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2278

Asia-Pacific is projected to grow at the highest CAGR of 5.9% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for the market growth.

The major companies profiled in the report include Stryker Corporation, Medtronic Plc., Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, and Acandis GmbH & Co. KG.

Contact: David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Devices Market Like to Touch $3,409 Million by 2023 here

News-ID: 1946938 • Views: 273

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Neurovascular

Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Embolization Device Market: Competitive Dynamics & Global Outlook …
New report published by Market Research Report Store (MRRS) which offers insights on the global Neurovascular Embolization Device market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/242161/global-neurovascular-embolization-device-market Global Neurovascular Embolization Device Market: Forecast by Type / Application / Region According to this study, over the next five years the Neurovascular Embolization Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million
Global Neurovascular Devices Market: Rising Geriatric Population and Neurovascul …
Besides exponential rise in occurrences of critical neurovascular ailments such as ischemic stroke and aneurysm amongst others, burgeoning advances in product enhancements, improved reimbursements, and surged healthcare expenditure are accounted to etch growth in global neurovascular devices market in forthcoming years. These market highlights are in line with Market Research Hub's (MRH) recent research report titled, 'Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and
Future For Neurovascular Devices Market...By 2024
MaketStudyReport.com adds a New Neurovascular Devices Market Research Report for the period of 2018 - 2024 that shows the growth of the market for next few years along with providing a competitive landscape. Neurovascular Devices Market will reach USD 2.0 billion by 2024; as per a new research report. Increasing incidences and financial cost burden associated with neurological disorders such as acute ischemic stroke and brain aneurysm will drive neurovascular devices industry
Neurovascular Devices Market - Regional Outlook 2017 - 2025
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In recent years, advances in balloon- and stent- assisted coiling in endovascular therapies have expanded the options for surgeons and patients in the treatment of aneurysms. The rising morbidity and mortality
Neurovascular Devices Market Growth and Forecast-2026
Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. The surgical procedure or specialty for the treatment of neurovascular diseases is called neurosurgery. Neurology is the medicine branch that deals with the disorders of the entire nervous system and brain. Interventional neurology deals with the treatment and diagnosis of all categories